Company profile: iScreen Vision
1.1 - Company Overview
Company description
- Provider of pediatric vision photoscreening devices and services, featuring the iScreen Vision Screener 3000 to detect major amblyopia risk factors and other serious eye problems through digital imaging, certified analysis of captured images, on-site and remote training, billing and customer support, and a 30-day risk-free trial with training, billing help, and regular check-ins.
Products and services
- Photoscreening Analysis: Clinician-reviewed service where digital images from the iScreen Vision Screener 3000 are evaluated by certified ophthalmic professionals to identify pediatric vision issues
- IScreen Vision Screener 3000: Digital-imaging-based photoscreener engineered for pediatric use, detecting major amblyopia risk factors and other serious eye problems via on-device image capture and analysis
- Risk-Free Trial: 30-day time-bound trial offering the Screener 3000 at no cost, with billing support, training, and regular check-ins to assess practice fit and integration
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to iScreen Vision
Viridian Pharma
HQ: United Kingdom
Website
- Description: Provider of niche pharmaceutical products for hospital use, developed and marketed in the UK. Established in 2002 and now part of Martindale Pharma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Viridian Pharma company profile →
Capnia
HQ: United States
Website
- Description: Provider of non-invasive neonatal hemolysis monitoring and diagnostics via the CoSense ETCOc Monitor and ETCOc Testing, which measure end-tidal carbon monoxide to assess bilirubin production and risks of hyperbilirubinemia and kernicterus; also developer of therapeutic products for chronic diseases using a proprietary medical gas delivery system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capnia company profile →
Renaissance Pharma
HQ: United Kingdom
Website
- Description: Provider of clinical-stage pharmaceutical development focused on life-changing therapies in pediatric rare diseases, including Hu14.18K322A (Hu14.18), a humanized anti-GD2 antibody developed for treating high-risk neuroblastoma, showing improved survival rates when combined with chemotherapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renaissance Pharma company profile →
Baebies
HQ: United States
Website
- Description: Provider of early disease detection and diagnostic solutions, including SEEKER, a newborn screening laboratory solution performing multiple assays from a single dried blood spot punch; FINDER, a near-patient testing platform using 50 microliters of blood to test for conditions like G6PD deficiency; and digital microfluidics to electrically control droplets for bioassay protocols.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Baebies company profile →
BabyBloom Healthcare
HQ: The Netherlands
Website
- Description: Provider of leading neonatology equipment that creates warm, safe, and comfortable environments for babies worldwide, supporting parents and medical staff; based in the Leiden BioSciencePark in the Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BabyBloom Healthcare company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for iScreen Vision
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to iScreen Vision
2.2 - Growth funds investing in similar companies to iScreen Vision
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for iScreen Vision
4.2 - Public trading comparable groups for iScreen Vision
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →